Feedback / Questions
izokibep (ABY-035) - Affibody, ACELYRIN
https://www.prnewswire.com/news-releases/acelyrin-inc-affibody-ab-and-inmagene-biopharmaceuticals-announce-positive-interim-results-from-global-phase-2-trial-of-izokibep-in-patients-with-psoriatic-arthritis-301443555.html
Dec 14, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next